Provided by Tiger Trade Technology Pte. Ltd.

BridgeBio Pharma, Inc.

68.31
+0.40000.59%
Volume:2.51M
Turnover:171.08M
Market Cap:13.24B
PE:-16.33
High:68.97
Open:67.91
Low:67.11
Close:67.91
52wk High:84.94
52wk Low:28.33
Shares:193.86M
Float Shares:151.20M
Volume Ratio:0.70
T/O Rate:1.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1844
EPS(LYR):-2.8793
ROE:-1789.67%
ROA:-43.47%
PB:-6.85
PE(LYR):-23.72

Loading ...

Feb 19, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 17, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 17, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 13, 2026

Major Issues Report

Form 8-K - Current report
Jan 21, 2026

Major Issues Report

Form 8-K - Current report
Jan 12, 2026

Major Issues Report

Form 8-K - Current report
Jan 08, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 08, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 29, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 29, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 29, 2025

Major Issues Report

Form 8-K - Current report
Oct 29, 2025

Major Issues Report

Form 8-K - Current report